X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare, Analyse JUBILANT LIFE SCIENCES with TEVA PHARMACEUTICAL INDUSTRIES LTD. - Israel - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

JUBILANT LIFE SCIENCES vs TEVA PHARMA (Israel) - Comparison Results

TEVA PHARMA (Israel)
   Change

Teva Pharmaceuticals, established in 1901, is a global pharmaceutical company. The company is into development, production and marketing of a wide range of specialty medicines, generic and OTC products, active pharmaceutical ingredients (API) and nov... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 JUBILANT LIFE SCIENCES   TEVA PHARMA
EQUITY SHARE DATA
    JUBILANT LIFE SCIENCES
Mar-14
TEVA PHARMA
Dec-13
JUBILANT LIFE SCIENCES/
TEVA PHARMA
5-Yr Chart
Click to enlarge
High Rs1873,001-   
Low Rs652,607-   
Sales per share (Unadj.) Rs364.31,722.1-  
Earnings per share (Unadj.) Rs6.8107.6-  
Cash flow per share (Unadj.) Rs24.5246.8-  
Dividends per share (Unadj.) Rs3.0094.18-  
Dividend yield (eoy) %2.43.4 70.9%  
Book value per share (Unadj.) Rs164.91,913.0-  
Shares outstanding (eoy) m159.28848.00-   
Bonus/Rights/Conversions ---  
Price / Sales ratio x0.31.6 21.2%   
Avg P/E ratio x18.426.1 70.6%  
P/CF ratio (eoy) x5.111.4 45.3%  
Price / Book Value ratio x0.81.5 52.1%  
Dividend payout %43.887.5 50.1%   
Avg Mkt Cap Rs m20,0612,377,546 0.8%   
No. of employees `0006.244.9 13.8%   
Total wages/salary Rs m11,0520-   
Avg. sales/employee Rs Th9,383.032,492.5 28.9%   
Avg. wages/employee Rs Th1,786.90-   
Avg. net profit/employee Rs Th176.32,029.8 8.7%   
INCOME DATA
Net Sales Rs m58,0341,460,373 4.0%  
Other income Rs m1910-   
Total revenues Rs m58,2241,460,373 4.0%   
Gross profit Rs m5,786399,924 1.4%  
Depreciation Rs m2,812118,043 2.4%   
Interest Rs m3,23728,684 11.3%   
Profit before tax Rs m-72253,197 -0.0%   
Minority Interest Rs m-2861,150 -24.9%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m2,145-166,210 -1.3%   
Tax Rs m696-3,091 -22.5%   
Profit after tax Rs m1,09091,228 1.2%  
Gross profit margin %10.027.4 36.4%  
Effective tax rate %-965.9-1.2 79,112.4%   
Net profit margin %1.96.2 30.1%  
BALANCE SHEET DATA
Current assets Rs m29,280986,331 3.0%   
Current liabilities Rs m38,912860,164 4.5%   
Net working cap to sales %-16.68.6 -192.1%  
Current ratio x0.81.1 65.6%  
Inventory Days Days8491 92.9%  
Debtors Days Days5196 52.8%  
Net fixed assets Rs m55,712476,990 11.7%   
Share capital Rs m1553,595 4.3%   
"Free" reserves Rs m20,9680-   
Net worth Rs m26,2651,622,198 1.6%   
Long term debt Rs m17,169746,721 2.3%   
Total assets Rs m88,6063,337,421 2.7%  
Interest coverage x1.09.8 9.9%   
Debt to equity ratio x0.70.5 142.0%  
Sales to assets ratio x0.70.4 149.7%   
Return on assets %4.93.6 135.9%  
Return on equity %4.25.6 73.8%  
Return on capital %11.64.9 234.6%  
Exports to sales %37.80-   
Imports to sales %16.50-   
Net fx Rs m10,2550-   
CASH FLOW
From Operations Rs m8,026232,708 3.4%  
From Investments Rs m-1,744-82,458 2.1%  
From Financial Activity Rs m-4,447-279,149 1.6%  
Net Cashflow Rs m1,834-128,899 -1.4%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for TEVA PHARMA (Israel) is United States Dollars. All data has been converted at 71.89 Rs / USD

Compare JUBILANT LIFE SCIENCES With: ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  

Compare JUBILANT LIFE SCIENCES With: AUROBINDO PHARMA  WOCKHARDT LTD.  DR. REDDYS LAB  DR. DATSONS LABS  DIVIS LABORATORIES  



Today's Market

Sensex Trades Marginally Higher; Yes Bank & Tata Motors Top Gainers(12:30 pm)

Share markets in India are presently trading on a positive note. Sectoral indices are trading on a positive note with stocks in the realty sector.

Related Views On News

JUBILANT LIFE SCIENCES Announces Quarterly Results (2QFY19); Net Profit Up 67.2% (Quarterly Result Update)

Nov 9, 2018 | Updated on Nov 9, 2018

For the quarter ended September 2018, JUBILANT LIFE SCIENCES has posted a net profit of Rs 2 bn (up 67.2% YoY). Sales on the other hand came in at Rs 23 bn (up 38.2% YoY). Read on for a complete analysis of JUBILANT LIFE SCIENCES's quarterly results.

JUBILANT LIFE SCIENCES Announces Quarterly Results (1QFY19); Net Profit Up 39.4% (Quarterly Result Update)

Jul 31, 2018 | Updated on Jul 31, 2018

For the quarter ended June 2018, JUBILANT LIFE SCIENCES has posted a net profit of Rs 2 bn (up 39.4% YoY). Sales on the other hand came in at Rs 21 bn (up 30.2% YoY). Read on for a complete analysis of JUBILANT LIFE SCIENCES's quarterly results.

More Views on News

Most Popular

These Are the Kind of Blue Chips You Should Invest In(The 5 Minute Wrapup)

Nov 9, 2018

All blue chip companies are large caps but all large caps are not blue chips.

Get this Small Cap Logistics Company at a 16% Discount Right Now...(Profit Hunter)

Nov 6, 2018

If you turn the clock back, the current macroeconomic climate is nothing new. The markets have seen them all, and every downcycle has been succeeded by gravity defying gains...more so in the small cap space. This time will be no different.

This Was a Large Cap. But Was It Safe?(Chart Of The Day)

Nov 9, 2018

Investing in large caps is not always safe. Consider the right metrics to judge the safety and quality of large caps.

Why the Realty Sector's Recovery Has Been Delayed(Sector Info)

Nov 15, 2018

NBFC and IL&FS crisis have worsened the realty sector woes. Is there a light at the end of the tunnel for real estate sector?

Does it Make Sense to Invest in Offshore Funds?(Outside View)

Nov 6, 2018

Many investors prefer to invest in offshore funds because of the rupee depreciation and on-going downtrend in the markets, but it is to be invested only when there is no option available to invest in India.

More

Small Investments
BIG Returns

Zero To Millions Guide 2019
Get our special report, Zero To Millions
(2019 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

JUBILANT LIFE SCIENCES SHARE PRICE


Nov 19, 2018 03:21 PM

TRACK JUBILANT LIFE SCIENCES

  • Track your investment in JUBILANT LIFE SCIENCES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON JUBILANT LIFE SCIENCES

JUBILANT LIFE SCIENCES 8-QTR ANALYSIS

COMPARE JUBILANT LIFE SCIENCES WITH

MARKET STATS